| Application no. and date | 17816489.3 (espacenet) (Federated) (European Patent Register), 20171123 | | Patent/reg. no. and date | DK/EP 3544637, 20201111 | | Publication date | 20191002 | | Priority no. and date | GB 201619949, 20161125, GB 201712101, 20170727 | | EP pub. no. and date |
EP 3544637 20191002 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals S.A., Rue de l'Institut, 89
1330 Rixensart, BE | | Applicant ref. no. | 164325 | | Inventor | SAUL, Allan James, GSK Vaccines Institute for Global Health S.r.l.
Via Fiorentina 1
53100 Siena, IT,
DI BENEDETTO, Roberta, GSK Vaccines Institute for Global Health S.r.l.
Via Fiorentina 1
53100 Siena, IT,
MICOLI, Francesca, GSK Vaccines Institute for Global Health S.r.l.
Via Fiorentina 1
53100 Siena, IT | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/015 (2006.01) , A61K 39/095 (2006.01) , A61K 39/112 (2006.01) , A61K 47/64 (2017.01) , A61K 47/69 (2017.01) , A61P 31/04 (2006.01) , A61P 33/06 (2006.01) | | Title | NATIVE OMV-ANTIGENKONJUGATER OG ANVENDELSE DERAF | | Int. application no. | EP2017080151 | | Int. publication no. | WO2018096013 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
